Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Endometriosis is a common estrogen-dependent disorder. Medical treatments currently consist of progestins or GnRH agonists; however, neither is fully effective and both entail significant side effects. Selective estrogen receptor (ER) modulators (SERM) have tissue-selective actions, acting as an ER agonist in some tissues and ER antagonist in others. The SERM bazedoxifene (BZA) effectively antagonizes estrogen-induced uterine endometrial stimulation without countering estrogenic effects in bone or central nervous system. These properties make it an attractive candidate for use in the treatment of endometriosis. Experimental endometriosis was created in reproductive-age CD-1 mice. After 8 wk, 10 animals received i.p. injections of BZA (3 mg/kg·d) for 8 wk, whereas 10 received vehicle control. Mice were killed, and implant size was assessed. The mean size of the implants after treatment was 60 mm(2) in the control group and 21 mm(2) in the BZA treatment group (P = 0.03). Quantitative PCR and immunohistochemical analysis were used to determine the effect on endometrial gene expression. PCNA, ERα, and LIF mRNA and protein expression were significantly decreased in endometrium of the treated group. Caspase 3 mRNA expression was increased. Expression of PR and Hoxa10 were not significantly altered by treatment. There was no evidence of ovarian enlargement or cyst formation. Decreased PCNA and ER expression demonstrated that the regression of endometriosis likely involved decreased estrogen-mediated cell proliferation. BZA may be an effective novel agent for the treatment of endometriosis due to greater endometrial-specific estrogen antagonism compared with other SERM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Prentice, A., Deary, A., Goldbeck-Wood, S., Farquhar, C., & Smith, S. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000346 · Cited by 116
RetractedGiudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
Black, L. J., Sato, M., Rowley, E. R., Magee, D. E., Bekele, A., Williams, D. C., Cullinan, G. J., Bendele, R., Kauffman, R. F., & Bensch, W. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116985 · Cited by 609
Contribution of Bone Marrow-Derived Stem Cells to Endometrium and Endometriosis
Du, H., & Taylor, H. S. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0828 · Cited by 449 · cited 1×
“an alternative theory for the etiology of endometriosis (3).”
BackgroundSelf-citationPathogenic mechanisms in endometriosis-associated infertility
Gupta, S., Goldberg, J. M., Aziz, N., Goldberg, E., Krajcir, N., & Agarwal, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.093 · Cited by 409
HOX gene expression is altered in the endometrium of women with endometriosis
Taylor, H. S. (1999) · Human Reproduction · doi:10.1093/humrep/14.5.1328 · Cited by 373
Self-citationStem Cells and the Pathogenesis of Endometriosis
Sasson, I. E., & Taylor, H. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1434.014 · Cited by 371
Self-citationNonsteroidal anti-inflammatory drugs for pain in women with endometriosis
Brown, J., Crawford, T. J., Allen, C., Hopewell, S., & Prentice, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004753.pub4 · Cited by 308
Ovulation suppression for endometriosis
Hughes, E., Fedorkow, D., Collins, J., & Vandekerckhove, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000155 · Cited by 245
Research works printed but not linked: 5
- Keskin, S. M., Gülerman, H. C., Moraloğlu, Ö., Uzunlar, Ö., Özyer, Ş., Aktulay, A., & Çaydere, M. (2013). SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 10(39), 1604-1608. https://doi.org/10.1210/en.2010-1010. Epub 2011 May 17.
- Keskin SM, Gülerman HC, Moraloğlu Ö, vd. SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ. JGON. 2013;10(39):1604-1608. doi:10.1210/en.2010-1010. Epub 2011 May 17.
- Keskin, Senem Mine, Hacer Cavidan Gülerman, Özlem Moraloğlu, vd. 2013. “SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 10 (39): 1604-8. https://doi.org/10.1210/en.2010-1010. Epub 2011 May 17.
- Keskin SM, Gülerman HC, Moraloğlu Ö, Uzunlar Ö, Özyer Ş, Aktulay A, Çaydere M. SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ. JGON. 2013;10:1604–1608.
- Senem Mine Keskin, Hacer Cavidan Gülerman, Özlem Moraloğlu, Özlem Uzunlar, Şebnem Özyer, Ayla Aktulay, Muzaffer Çaydere. SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ. JGON. 01 Temmuz 2013;10(39):1604-8. doi:10.1210/en.2010-1010. Epub 2011 May 17.
Cited by
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Self-citationProgesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?
Marquardt, R. M., Kim, T. H., Shin, J.-H., & Jeong, J.-W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153822 · Cited by 491
The Origin and Pathogenesis of Endometriosis
Wang, Y., Nicholes, K., & Shih, I.-M. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032654 · Cited by 455
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Endometriosis-associated infertility: From pathophysiology to tailored treatment
Bonavina, G., & Taylor, H. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020827 · Cited by 319
Self-citationEstrogen Receptors and Endometriosis
Chantalat, E., Valera, M.-C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., Vergriete, K., Buscail, E., Lluel, P., Fontaine, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082815 · Cited by 297
Nuclear Receptors and Their Selective Pharmacologic Modulators
Burris, T. P., Solt, L. A., Wang, Y., Crumbley, C., Banerjee, S., Griffett, K., Lundasen, T., Hughes, T., & Kojetin, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006833 · Cited by 283
Estrogen receptors and human disease: an update
Burns, K. A., & Korach, K. S. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0868-5 · Cited by 275
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways
Patel, B. G., Lenk, E. E., Lebovic, D. I., Shu, Y., Yu, J., & Taylor, R. N. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.006 · Cited by 191
Endometriosis: where are we and where are we going?
Greene, A. D., Lang, S. A., Kendziorski, J. A., Sroga-Rios, J. M., Herzog, T. J., & Burns, K. A. (2016) · Reproduction · doi:10.1530/rep-16-0052 · Cited by 187
New developments in the medical treatment of endometriosis
Bedaiwy, M. A., Alfaraj, S., Yong, P., & Casper, R. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.025 · Cited by 176
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Zhao, Y., Gong, P., Chen, Y., Nwachukwu, J. C., Srinivasan, S., Ko, C., Bagchi, M. K., Taylor, R. N., Korach, K. S., Nettles, K. W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010626 · Cited by 170
“Here, we have evaluated the efficacy of OBHS and CLI in treating endometriosis in a validated murine model in which endometriosis-like lesion establishment and progression are estrogendependent, similar to the clinical syndrome (14, 15).”
MethodReis, F. M., Coutinho, L. M., Vannuccini, S., Batteux, F., Chapron, C., & Petraglia, F. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa009 · Cited by 166
Pharmacologic therapies in endometriosis: a systematic review
Soares, S. R., Martínez‐Varea, A., Hidalgo‐Mora, J. J., & Pellicer, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1120 · Cited by 165
Burns, K. A., Rodriguez, K. F., Hewitt, S. C., Janardhan, K. S., Young, S. L., & Korach, K. S. (2012) · Endocrinology · doi:10.1210/en.2012-1294 · Cited by 153
Current and emerging treatment options for endometriosis
Ferrero, S., Evangelisti, G., & Barra, F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1494154 · Cited by 152
“Furthermore, in vitro and animal studies showed that BZA is able to cause regression of endometriotic lesions [95,96], inhibiting estrogen-mediated cell proliferation [95] as well as decreasing stem cell recruitment within the endometriotic lesions [96].”
BackgroundNelson, E. R., Wardell, S. E., & McDonnell, D. P. (2013) · Bone · doi:10.1016/j.bone.2012.11.011 · Cited by 134
The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis
Hufnagel, D., Li, F., Cosar, E., Krikun, G., & Taylor, H. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1564609 · Cited by 133
Self-citationThe Endometrium as a Source of Mesenchymal Stem Cells for Regenerative Medicine1
Mutlu, L., Hufnagel, D., & Taylor, H. S. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.126771 · Cited by 116
Self-citationHan, S. J., & O'Malley, B. W. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu002 · Cited by 99
Hormonal therapy for endometriosis: from molecular research to bedside
Tosti, C., Biscione, A., Morgante, G., Bifulco, G., Luisi, S., & Petraglia, F. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.032 · Cited by 96
Sakr, S., Naqvi, H., Komm, B., & Taylor, H. S. (2014) · Endocrinology · doi:10.1210/en.2013-1977 · Cited by 91
Self-citationNew Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments
Brichant, G., Laraki, I., Henry, L., Munaut, C., & Nisolle, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910498 · Cited by 111
Medical treatment for adenomyosis and/or adenomyoma
Tsui, K., Lee, W.-L., Chen, C.-Y., Sheu, B., Yen, M., Chang, T., & Wang, P. (2014) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.04.024 · Cited by 89
Androgens, oestrogens and endometrium: a fine balance between perfection and pathology
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0106 · Cited by 76
Fu, S., Chen, X. '., Lo, H., & Lin, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.026 · Cited by 79
Zhang, B., Zhou, W., Gu, C., Wu, K., Yang, H., Mei, J., Yu, J.-J., Hou, X.-F., Sun, J., Xu, F., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0581-2 · Cited by 75
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1581761 · Cited by 69
Abbas, A. M., Samy, A., Atwa, K. A., Ghoneim, H. M., Lotfy, M., Mohammed, H. S., Abdellah, A. M., Elbahie, A. M., Aboelroose, A. A., Elgedawy, A. M., et al. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13798 · Cited by 66
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis
Clemenza, S., Sorbi, F., Noci, I., Capezzuoli, T., Turrini, I., Carriero, C., Buffi, N., Fambrini, M., & Petraglia, F. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.021 · Cited by 63
Tissue-selective estrogen complexes for postmenopausal women
Mirkin, S., & Komm, B. S. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.06.003 · Cited by 68
Self-citationKomm, B. S., Mirkin, S., & Jenkins, S. N. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.004 · Cited by 66
Self-citationNew trends for the medical treatment of endometriosis
Rocha, A. L. L., Reis, F. M., & Petraglia, F. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.683783 · Cited by 60
Investigational drugs for the treatment of endometriosis, an update on recent developments
Barra, F., Scala, C., Mais, V., Guerriero, S., & Ferrero, S. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1471135 · Cited by 57
Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model
Burns, K. A., Pearson, A. M., Slack, J. L., Por, E. D., Scribner, A. N., Eti, N. A., & Burney, R. O. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.806574 · Cited by 66
Naqvi, H., Sakr, S., Presti, T., Krikun, G., Komm, B., & Taylor, H. S. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.114165 · Cited by 54
Self-citationThe Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility
Li, J.-J., Chung, J. P. W., Wang, S., Li, T. C., & Duan, H. (2018) · BioMed Research International · doi:10.1155/2018/6832685 · Cited by 64
Pluchino, N., Mamillapalli, R., Wenger, J., Ramyead, L., Drakopoulos, P., Tille, J., & Taylor, H. S. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.01.036 · Cited by 52
Self-citationPathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways
Kane, M. A., Sidell, N., & Taylor, R. N. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554920 · Cited by 49
Differential effects of menopausal therapies on the endometrium
Mirkin, S., Archer, D. F., Taylor, H. S., Pickar, J. H., & Komm, B. S. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000186 · Cited by 48
Self-citationEmerging therapy for endometriosis
Lindsay, S. F., Luciano, D. E., & Luciano, A. A. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1051966 · Cited by 45
Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials
Komm, B. S., Thompson, J. R., & Mirkin, S. (2014) · Climacteric · doi:10.3109/13697137.2014.992011 · Cited by 37
Self-citationNovel pharmacological therapies for the treatment of endometriosis
Buggio, L., Dridi, D., Barbàra, G., Merli, C. E. M., Cetera, G. E., & Vercellini, P. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2117155 · Cited by 46
Evolution of the tissue selective estrogen complex (TSEC)
Komm, B. S., & Mirkin, S. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24324 · Cited by 35
Self-citationAdvances in targeting estrogen synthesis and receptors in patients with endometriosis
Clemenza, S., Vannuccini, S., Ruotolo, A., Capezzuoli, T., & Petraglia, F. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2152325 · Cited by 38
Novel agents for the medical treatment of endometriosis
Platteeuw, L., & D’Hooghe, T. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000084 · Cited by 37
Skouby, S. O., Pan, K., Thompson, J. R., Komm, B. S., & Mirkin, S. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000362 · Cited by 33
Self-citationResearch advances in drug therapy of endometriosis
Shi, J., Tan, X., Feng, G., Yuan, Z., Jiang, Z., Banda, S., Wang, L., Zheng, W., Chen, L., Yu, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1199010 · Cited by 40
Understanding Endometriosis: A Broad Review of Its Causes, Management, and Impact
Czubak, P., Herda, K., Niewiadomska, I., Putowski, L. T., Łańcut, M., & Masłyk, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188878 · Cited by 44
Harada, T., Ohta, I., Endo, Y., Sunada, H., Noma, H., & Taniguchi, F. (2017) · Yonago acta medica · doi:10.33160/yam.2017.12.003 · Cited by 28
Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model
Pinkerton, J. V., Komm, B. S., & Mirkin, S. (2013) · Climacteric · doi:10.3109/13697137.2013.810437 · Cited by 31
Self-citationArcher, D. F., Carr, B. R., Pinkerton, J. V., Taylor, H. S., & Constantine, G. D. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000365 · Cited by 22
Self-citationMedical Therapies for Endometriosis Differentially Inhibit Stem Cell Recruitment
Ersoy, G. Ş., Zolbin, M. M., Çoşar, E., Mamillapalli, R., & Taylor, H. S. (2017) · Reproductive Sciences · doi:10.1177/1933719116682879 · Cited by 20
Self-citationEstrogen-Induced CCN1 Is Critical for Establishment of Endometriosis-Like Lesions in Mice
Zhao, Y., Li, Q., Katzenellenbogen, B. S., Lau, L. F., Taylor, R. N., Bagchi, I. C., & Bagchi, M. K. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1080 · Cited by 22
Chang, L.-C., Chiang, Y., Chen, H.-Y., Huang, Y.-J., Liu, A.-C., & Hsia, S. (2020) · Biomedicines · doi:10.3390/biomedicines8110528 · Cited by 19
Innovations in classical hormonal targets for endometriosis
Pluchino, N., Freschi, L., Wenger, J., & Streuli, I. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1129895 · Cited by 19
A review of phase II and III drugs for the treatment and management of endometriosis
Perrone, U., Evangelisti, G., Laganà, A. S., Bogliolo, S., Ceccaroni, M., Izzotti, A., Gustavino, C., Ferrero, S., & Barra, F. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2296080 · Cited by 20
New insights on the pathogenesis of endometriosis and novel non-surgical therapies
Suardika, A., & Pemayun, T. G. A. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0090 · Cited by 22
Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
Omotuyi, O. I., Olatunji, O. M., Nash, O., Oyinloye, B. E., Soremekun, O. S., Ijagbuji, A. A., & Fatumo, S. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.105994 · Cited by 17
Zhao, Y., Chen, Y., Kuang, Y., Bagchi, M. K., Taylor, R. N., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2015) · Endocrinology · doi:10.1210/en.2015-1324 · Cited by 17
Endometriosis — insights into a multifaceted entity
Amălinei, C., Păvăleanu, I., Lozneanu, L., Balan, R. A., Giuşcă, S. E., & Căruntu, I.-D. (2018) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2018.0013 · Cited by 19
Medical management of endometriosis
Newmark, A., Luciano, D. E., Ulrich, A., & Luciano, A. A. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04776-x · Cited by 16
Flannery, C. A., Fleming, A. G., Choe, G. H., Naqvi, H., Zhang, M., Sharma, A. R., & Taylor, H. S. (2016) · Endocrinology · doi:10.1210/en.2016-1233 · Cited by 16
Self-citationWilczyński, J. R., Szubert, M., Paradowska, E., & Wilczyński, M. (2022) · Cancers · doi:10.3390/cancers15010111 · Cited by 19
Bazedoxifene–Conjugated Estrogens for Treating Endometriosis
Flores, V. A., Stachenfeld, N. S., & Taylor, H. S. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002739 · Cited by 15
Self-citationThe influence of mifepristone to caspase 3 expression in adenomyosis
Wang, Y., Jiang, X., & Wang, S. (2014) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog15872014 · Cited by 15
Emerging hormonal treatments for menopausal symptoms
Genazzani, A. R., Komm, B. S., & Pickar, J. H. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.986093 · Cited by 15
Self-citationMikuš, M., Goldštajn, M. Š., Laganà, A. S., Vukorepa, F., & Ćorić, M. (2023) · Pharmaceuticals · doi:10.3390/ph16091315 · Cited by 20
Kagan, R., Goldstein, S. R., Pickar, J. H., & Komm, B. S. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s63833 · Cited by 14
Self-citationOthman, E. R., Meligy, F. Y., Sayed, A. A.-R., El‐Mokhtar, M. A., & Refaiy, A. M. (2018) · Reproductive Sciences · doi:10.1177/1933719117697124 · Cited by 14
Hormone therapy in menopausal women with fibroids: is it safe?
Srinivasan, V., & Martens, M. G. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001105 · Cited by 12
Predictive Biomarkers May allow Precision Therapy of Endometriosis
Hou, Z., Mamillapalli, R., & Taylor, H. S. (2017) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/jeppd.5000311 · Cited by 12
Self-citationAn overview of early drug development for endometriosis
Maggiore, U. L. R., & Ferrero, S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1126579 · Cited by 11
Burns, K. A., Peterse, D., Appleyard, C. B., Chandler, R. L., Guo, S., Pearson, A. M., Persoons, E., Anglesio, M. S., Rogers, M. S., Sharpe-Timms, K. L., et al. (2025) · Molecular Human Reproduction · doi:10.1093/molehr/gaaf021 · Cited by 12
Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
Hill, A., Lessey, B. A., Flores, V. A., & Taylor, H. S. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1501 · Cited by 8
Self-citationThe prospects of cell therapy for endometriosis
Artemova, D. A., Vishnyakova, P., Gantsova, E. A., Elchaninov, A. V., Fatkhudinov, T., & Sukhikh, G. T. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02772-5 · Cited by 11
Kotb, M. A., Abdelmawgood, I. A., WalyEldeen, A. A., Abdelaziz, M. H., Khalaf, M. L., Mohamed, A. S., Dakrory, A. E., & Ibrahim, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106984 · Cited by 10
Experimental Treatments of Endometriosis
Attar, R., & Attar, E. (2015) · Women s Health · doi:10.2217/whe.15.51 · Cited by 8
The latest advances in the pharmacological management of endometriosis
Hartner, G., Husslein, H., Kuessel, L., Gstoettner, M., Tiringer, D., Wenzl, R. J., & Perricos, A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2045274 · Cited by 9
Flores, V. A., Leone, C. A., Taylor, H. S., & Stachenfeld, N. S. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1559288 · Cited by 8
Self-citationHost immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis.
Grande, J. P., Jones, T. L., Sun, Z., Chanana, P., Jaiswal, I., Leontovich, A. A., Carapanceanu, N., Carapanceanu, V., Saadalla, A. M., Osman, A., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166784 · Cited by 7
Biased Signaling and Conformational Dynamics in Nuclear Hormone Receptors
Flaveny, C. A., Solt, L. A., Kojetin, D. J., & Burris, T. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411460-9.00004-5 · Cited by 5
Omenge, H., Kempa, P. A., Jeong, J.-W., So, K. A., & Kim, T. H. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag019 · Cited by 8
Flores, V. A., Şahin, Ç., & Taylor, H. S. (2024) · F&S Science · doi:10.1016/j.xfss.2024.10.004 · Cited by 5
Self-citationGiles, E. D., Cook, K. L., Jenschke, R. M., Corleto, K. A., Landrock, D., Mahmood, T. N., Sanchez, K. E., Levin, A., Hursting, S. D., Kimler, B. F., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.182694 · Cited by 6
Self-citationKiba, A., Banno, K., Yanokura, M., Asada, M., Nakayama, Y., Aoki, D., & Watanabe, T. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12768 · Cited by 4
Yu, C.-X., Song, J., & Liang, L. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.955467 · Cited by 3
The Role of Epigenetics in Endometriosis
Widhusadi, N. L. W. A., & Anantasika, A. A. N. (2023) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2183 · Cited by 2
Gupta, S., Harlev, A., Agarwal, A. K., Rakhit, M., Ellis-Kahana, J., & Parikh, S. (2015) · SpringerBriefs in reproductive biology · doi:10.1007/978-3-319-18308-4_10 · Cited by 2
Medikamentozno zdravljenje endometrioze: pregled stanja in nove možnosti zdravljenja
Jakič, M., Vogler, A., & Rižner, T. L. (2016) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1416 · Cited by 3
Makoui, R. H., Fekri, S. M., Ansari, N. E., & Makoui, M. H. (2024) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2024.82610 · Cited by 1
Hernández-Hernández, O. T., Velázquez-Hernández, D. M., & Camacho‐Arroyo, I. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070649 · Cited by 2
Endometriosis in Experimental Models
Taniguchi, F., & Harada, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_14 · Cited by 2
Endometriosis and Adenomyosis in Adolescents and Fertile and Menopausal Women
Adamyan, L. V. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_15 · Cited by 2
Pharmacological treatment of endometriosis: review of current and new options for treatment
Jakič, M., Vogler, A., & Rižner, T. L. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Investigational Medical Therapies for Endometriosis: Current Data and Future Trends
Zhang, R., Lebovic, D. I., & Kavoussi, S. K. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1604095 · Cited by 1
Endometrial Stem Cells and Endometriosis
Canosa, S., Carosso, A. R., Sestero, M., Revelli, A., & Bussolati, B. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-90111-0_8 · Cited by 1
Benefits and recently identified limitations of bazedoxifene acetate for postmenopausal symptoms
Pru, J. K. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318286cc45 · Cited by 1
Peterse, D., Verhassel, A., Fassbender, A., O, D. F., Vanhie, A., Rompuy, A. V., Saunders, P. T. K., Vriens, J., & D’Hooghe, T. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.28.583957 · Cited by 1
Metadata
- Authors
- Kulak, J., Fischer, C., Komm, B., & Taylor, H. S.
- Affiliations
- Yale University (US)
- Pfizer (United States) (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2011-05-17
- Volume
- 152
- Issue
- 8
- Pages
- 3226-3232
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC3138238
- OpenAlex
- W2152300718
- Cited by
- 112
- References
- 47
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 5 · 2019: 9 · 2018: 11 · 2017: 7 · 2016: 7 · 2015: 12 · 2014: 15 · 2013: 6 · 2012: 5
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrinology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD052668)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- bazedoxifene, selective estrogen receptor modulators, endometriosis, endometrial gene expression, estrogen receptor alpha, PCNA, LiF, caspase-3, endometrial proliferation, estrogen antagonism, mouse model
- MeSH terms
- Animals, Disease Models, Animal, Endometriosis, Female, Indoles, Receptors, Estrogen, Proliferating Cell Nuclear Antigen, Selective Estrogen Receptor Modulators, Mice, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.